TrialHuman vaccines & immunotherapeutics2026
Immunogenicity and safety of an investigational quadrivalent measles, mumps, rubella, and varicella vaccine in children aged 4-6 years: A phase II, randomized, multi-country trial.
Md Ahsan Habib et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.